JEOL Ltd. (6951) AI Stock Analysis

• Market Cap: ¥271.22B
• Dividend Yield: 1.94%
• Average Volume (3M): 223.67K
• Price to Earnings (P/E): 13.6
• Beta (1Y): 1.39
• Revenue Growth: 10.15%
• EPS Growth: -18.57%
• Country: JP
• Employees: 3,435
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 91.32
• Shares Outstanding: 51,532,800
• 10 Day Avg. Volume: 188,480
• 30 Day Avg. Volume: 223,666
• PEG Ratio: -0.90
• Price to Book (P/B): 1.71
• Price to Sales (P/S): 1.19
• P/FCF Ratio: 11.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥7,250.00
• Price Target Upside: 39.64% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 76 Outperform
• Price Target: ¥5,979.00 ▲(15.16% Upside)

JEOL Ltd. receives a strong overall score driven by its robust financial performance and positive technical indicators. The company's effective cash flow management and conservative leverage profile are significant strengths. While the valuation is fair, slight pressures on profitability margins and the absence of recent earnings call insights or corporate events slightly temper the overall outlook.

JEOL Ltd. Business Overview & Revenue Model

Company Description

JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. The company provides transmission electron microscopes; scanning electron microscopes; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for micro area and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; X-ray fluorescence spectrometers; mass spectrometers; electron beam lithography systems; and clinical chemistry analyzers. It also offers industrial equipment for thin-film formation and material processing, including thin film formation equipment and material processing equipment. The company was formerly known as Japan Electron Optics Laboratory Co., Ltd. and changed its name to JEOL Ltd. in 1961. JEOL Ltd. was founded in 1949 and is headquartered in Akishima, Japan.

How the Company Makes Money

JEOL Ltd. generates revenue primarily through the sale of its high-precision instruments and systems, including electron microscopes, mass spectrometers, and other analytical equipment. The company also earns income through maintenance and support services for its products, which ensures ongoing customer engagement. Additionally, JEOL has established partnerships with research institutions and universities, enhancing its market presence and driving sales through collaborative projects and research initiatives. As a result, the company benefits from both direct sales and long-term service contracts, contributing to a stable revenue stream.

JEOL Ltd. Financial Statement Overview

Summary

JEOL Ltd. displays strong financial performance with robust revenue growth and effective cash flow management. The company maintains a well-capitalized balance sheet with a conservative leverage profile. However, slight pressures on profitability margins and a decrease in ROE suggest areas for improvement.

Income Statement

JEOL Ltd. exhibits strong revenue growth with a consistent upward trajectory in Total Revenue over the past years, achieving a notable revenue growth rate of 12.8% from 2024 to 2025. The Gross Profit Margin remains healthy at around 47% in 2025, indicating efficient cost management. However, the Net Profit Margin slightly decreased from 12.5% in 2024 to 9.5% in 2025, which could suggest increased expenses or competitive pressures. The company maintains robust EBIT and EBITDA margins, reflecting solid operating performance.

Balance Sheet

JEOL Ltd. demonstrates financial stability with a strong Equity Ratio of 61.4% in 2025, indicating a well-capitalized balance sheet. The Debt-to-Equity ratio is low at 0.07, showcasing a conservative leverage position. However, Return on Equity (ROE) decreased from 17.3% in 2024 to 13.7% in 2025, suggesting that profitability growth is not keeping pace with equity growth, potentially impacting shareholder returns.

Cash Flow

The company shows impressive Free Cash Flow growth, increasing from ¥11.8 billion in 2024 to ¥20.1 billion in 2025, which enhances financial flexibility. The Operating Cash Flow to Net Income ratio is strong, indicating efficient cash generation relative to net earnings. The Free Cash Flow to Net Income ratio also improved, showcasing effective cash management and a healthy ability to fund operations and investments internally.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	200.49B	196.69B	174.34B	162.69B	138.41B	110.44B
Gross Profit	93.61B	92.40B	79.28B	72.70B	55.37B	42.89B
EBITDA	32.13B	30.26B	34.31B	28.71B	18.48B	9.44B
Net Income	19.46B	18.69B	21.70B	17.83B	12.28B	3.75B
Balance Sheet
Total Assets	220.17B	222.49B	230.21B	199.28B	189.56B	146.39B
Cash, Cash Equivalents and Short-Term Investments	40.76B	36.14B	31.50B	34.25B	44.23B	15.38B
Total Debt	6.17B	9.28B	15.78B	12.48B	17.11B	33.34B
Total Liabilities	82.70B	85.83B	104.70B	97.39B	103.66B	95.39B
Stockholders Equity	137.47B	136.65B	125.51B	101.89B	85.90B	51.00B
Cash Flow
Free Cash Flow	0.00	20.14B	11.83B	-3.04B	21.09B	-3.67B
Operating Cash Flow	0.00	23.10B	15.30B	3.35B	22.60B	3.36B
Investing Cash Flow	0.00	-855.00M	-18.03B	-5.73B	-648.00M	-6.99B
Financing Cash Flow	0.00	-17.12B	-798.00M	-8.73B	5.52B	3.29B

JEOL Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5192.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6951, the sentiment is Positive. The current price of 5192 is below the 20-day moving average (MA) of 5228.25, above the 50-day MA of 4981.46, and above the 200-day MA of 4706.78, indicating a neutral trend. The MACD of 60.85 indicates Positive momentum. The RSI at 53.18 is Neutral, neither overbought nor oversold. The STOCH value of 30.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6951.

JEOL Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4186	―	$615.50B	21.57	13.68%	1.16%	21.48%	65.56%
6951	―	¥271.22B	13.56	―	1.94%	10.15%	-18.57%
6856	―	$528.75B	14.59	11.91%	0.74%	7.09%	6.00%
7701	―	$1.15T	22.07	10.54%	1.50%	4.01%	-6.45%
6965	―	$493.13B	33.82	4.46%	2.19%	0.66%	-52.50%
6806	―	$649.71B	20.31	8.68%	2.45%	13.89%	11.34%
Sector *	―	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

JEOL Ltd. Corporate Events

JEOL Ltd. Transfers Medical Equipment Business to Sysmex for Strategic Growth

JEOL Ltd. has announced a strategic move to transfer its medical equipment business to a newly established subsidiary, which will then be acquired by Sysmex Corporation. This decision aims to leverage Sysmex’s strong industry presence and resources to drive sustainable growth and enhance JEOL’s corporate value through synergies in research, development, and business expansion.

The most recent analyst rating on (JP:6951) stock is a Buy with a Yen5332.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.

JEOL Ltd. Reports Strong Financial Growth in Q1 2025

JEOL Ltd. reported a significant increase in its consolidated financial results for the three months ended June 30, 2025, with a 10.4% rise in net sales and a 42.1% increase in operating profit compared to the previous year. Despite a decrease in comprehensive income, the company maintained a strong equity-to-asset ratio and announced stable dividend forecasts, indicating a robust financial position and positive outlook for stakeholders.

The most recent analyst rating on (JP:6951) stock is a Buy with a Yen10000.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.